156 related articles for article (PubMed ID: 12115809)
1. The influence of lipids on stereoselective pharmacokinetics of halofantrine: Important implications in food-effect studies involving drugs that bind to lipoproteins.
Brocks DR; Wasan KM
J Pharm Sci; 2002 Aug; 91(8):1817-26. PubMed ID: 12115809
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of Amiodarone in hyperlipidemic and simulated high fat-meal rat models.
Shayeganpour A; Jun AS; Brocks DR
Biopharm Drug Dispos; 2005 Sep; 26(6):249-57. PubMed ID: 15968713
[TBL] [Abstract][Full Text] [Related]
3. Association of halofantrine with postprandially derived plasma lipoproteins decreases its clearance relative to administration in the fasted state.
Humberstone AJ; Porter CJ; Edwards GA; Charman WN
J Pharm Sci; 1998 Aug; 87(8):936-42. PubMed ID: 9687337
[TBL] [Abstract][Full Text] [Related]
4. The effect of experimental hyperlipidemia on the stereoselective tissue distribution, lipoprotein association and microsomal metabolism of (+/-)-halofantrine.
Patel JP; Fleischer JG; Wasan KM; Brocks DR
J Pharm Sci; 2009 Jul; 98(7):2516-28. PubMed ID: 18972574
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of halofantrine in the rat: stereoselectivity and interspecies comparisons.
Brocks DR; Toni JW
Biopharm Drug Dispos; 1999 Apr; 20(3):165-9. PubMed ID: 10211870
[TBL] [Abstract][Full Text] [Related]
6. The stereoselective distribution of halofantrine enantiomers within human, dog, and rat plasma lipoproteins.
Brocks DR; Ramaswamy M; MacInnes AI; Wasan KM
Pharm Res; 2000 Apr; 17(4):427-31. PubMed ID: 10870986
[TBL] [Abstract][Full Text] [Related]
7. Effect of serum lipoproteins on stereoselective halofantrine metabolism by rat hepatocytes.
Patel JP; Hamdy DA; El-Kadi AO; Brocks DR
Chirality; 2012 Jul; 24(7):558-65. PubMed ID: 22589120
[TBL] [Abstract][Full Text] [Related]
8. Intravenous dosing conditions may affect systemic clearance for highly lipophilic drugs: implications for lymphatic transport and absolute bioavailability studies.
Caliph SM; Trevaskis NL; Charman WN; Porter CJ
J Pharm Sci; 2012 Sep; 101(9):3540-6. PubMed ID: 22623170
[TBL] [Abstract][Full Text] [Related]
9. Intestinal lymphatic transport of halofantrine in rats assessed using a chylomicron flow blocking approach: the influence of polysorbate 60 and 80.
Lind ML; Jacobsen J; Holm R; Müllertz A
Eur J Pharm Sci; 2008 Oct; 35(3):211-8. PubMed ID: 18675904
[TBL] [Abstract][Full Text] [Related]
10. Differences in the lipoprotein distribution of halofantrine are regulated by lipoprotein apolar lipid and protein concentration and lipid transfer protein I activity: in vitro studies in normolipidemic and dyslipidemic human plasmas.
Wasan KM; Ramaswamy M; McIntosh MP; Porter CJ; Charman WN
J Pharm Sci; 1999 Feb; 88(2):185-90. PubMed ID: 9950636
[TBL] [Abstract][Full Text] [Related]
11. Enhanced oral absorption of halofantrine enantiomers after encapsulation in a proliposomal formulation.
Brocks DR; Betageri GV
J Pharm Pharmacol; 2002 Aug; 54(8):1049-53. PubMed ID: 12195818
[TBL] [Abstract][Full Text] [Related]
12. The effect of increased lipoprotein levels on the pharmacokinetics of cyclosporine A in the laboratory rat.
Brocks DR; Ala S; Aliabadi HM
Biopharm Drug Dispos; 2006 Jan; 27(1):7-16. PubMed ID: 16278928
[TBL] [Abstract][Full Text] [Related]
13. Stereoselective pharmacokinetics of desbutylhalofantrine, a metabolite of halofantrine, in the rat after administration of the racemic metabolite or parent drug.
Brocks DR
Biopharm Drug Dispos; 2000 Dec; 21(9):365-71. PubMed ID: 11523065
[TBL] [Abstract][Full Text] [Related]
14. Effect of bile and lipids on the stereoselective metabolism of halofantrine by rat everted-intestinal sacs.
Patel JP; Korashy HM; El-Kadi AO; Brocks DR
Chirality; 2010 Feb; 22(2):275-83. PubMed ID: 19496124
[TBL] [Abstract][Full Text] [Related]
15. Comparison of total oral bioavailability and the lymphatic transport of halofantrine from three different unsaturated triglycerides in lymph-cannulated conscious rats.
Holm R; Müllertz A; Christensen E; Høy CE; Kristensen HG
Eur J Pharm Sci; 2001 Dec; 14(4):331-7. PubMed ID: 11684408
[TBL] [Abstract][Full Text] [Related]
16. Stereoselective halofantrine and desbutylhalofantrine disposition in the rat: cardiac and plasma concentrations and plasma protein binding.
Brocks DR
Biopharm Drug Dispos; 2002 Jan; 23(1):9-15. PubMed ID: 11891669
[TBL] [Abstract][Full Text] [Related]
17. Lymphatic transport of Methylnortestosterone undecanoate (MU) and the bioavailability of methylnortestosterone are highly sensitive to the mass of coadministered lipid after oral administration of MU.
White KL; Nguyen G; Charman WN; Edwards GA; Faassen WA; Porter CJ
J Pharmacol Exp Ther; 2009 Nov; 331(2):700-9. PubMed ID: 19696095
[TBL] [Abstract][Full Text] [Related]
18. A mouse model to evaluate the impact of species, sex, and lipid load on lymphatic drug transport.
Trevaskis NL; Caliph SM; Nguyen G; Tso P; Charman WN; Porter CJ
Pharm Res; 2013 Dec; 30(12):3254-70. PubMed ID: 23430484
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of dronedarone in normolipidemic and hyperlipidemic rats.
Jardan YA; Brocks DR
Biopharm Drug Dispos; 2016 Sep; 37(6):345-51. PubMed ID: 27194397
[TBL] [Abstract][Full Text] [Related]
20. Nonlinear stereoselective pharmacokinetics of ketoconazole in rat after administration of racemate.
Hamdy DA; Brocks DR
Chirality; 2009 Jul; 21(7):704-12. PubMed ID: 18988259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
